ZO-1 Monoclonal Antibody (ZO1-1A12) and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0477381
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $892.97
About this award
The University of Virginia awarded a contract to Life Technologies Corporation on September 5, 2026, for the delivery of monoclonal antibody products. The contract, identified as A207_PO-0477381, encompasses two distinct line items: ZO-1 Monoclonal Antibody (ZO1-1A12) valued at $523.32 and Occludin Monoclonal Antibody (OC-3F10) valued at $369.65. Both items are to be delivered to Daiki Kajioka. The total contract value is $892.
This procurement, executed in Virginia, represents a specialized life sciences purchase by the University of Virginia from Life Technologies Corporation for research-grade monoclonal antibody products. Each line item specifies a quantity of one unit, with deliverables consisting of distinct antibody reagents utilized in laboratory and research applications. The contract documentation does not specify an annual value or extended performance period, indicating this appears to be a single-purchase transaction for the identified materials.
Line items
| Item | Total |
|---|---|
| ZO-1 Monoclonal Antibody (ZO1-1A12) | $523.32 |
| Occludin Monoclonal Antibody (OC-3F10) | $369.65 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0477381?
Contract A207_PO-0477381 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on September 5, 2026.
How much is contract A207_PO-0477381 worth?
Its cumulative value is $892.97.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award